Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp (Nasdaq: FLAC) is a blank-check company sponsored by Frazier Life Sciences, a venture capital firm with an established track record investing in biopharmaceutical and medical technology companies. FLAC completed its initial public offering in 2021 and focuses on acquisition targets within the life sciences and biotechnology sectors. As of its 10-Q filing dated August 9, 2021, the company remained in the pre-combination phase, continuing its search for a suitable target business. The sponsor's deep sector expertise positions the vehicle to evaluate clinical-stage and commercial life sciences opportunities. Sign up at SpacDesk for full filings, timeline data, and analytics on FLAC and hundreds of other SPACs.